Rocky Mountain Cancer Center - Hale Parkway — Denver, Colorado

Rocky Mountain Cancer Center - Hale Parkway is a clinical research site located in Denver, Colorado, United States 80220.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Center - Hale Parkway has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasm, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Center - Hale Parkway?

Rocky Mountain Cancer Center - Hale Parkway has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Center - Hale Parkway conducted?

Rocky Mountain Cancer Center - Hale Parkway has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasm, Neoplasm Metastasis.

Is Rocky Mountain Cancer Center - Hale Parkway accredited by Crixeo Health?

Rocky Mountain Cancer Center - Hale Parkway has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Center - Hale Parkway?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.